Q. I remember reading about lecanemab, an Alzheimer’s treatment, in your newsletter earlier in the year. I have heard that there are other new treatments coming out to slow Alzheimer’s progression. Do you know what else is out there, and if it will be covered by Medicare? Thanks so much for your help! A. Good […]
FDA Approves New Alzheimer’s Drug That Slows Progression of the Disease
On January 6, 2023, the Food and Drug Administration approved the new Alzheimer’s drug lecanemab, which has been shown in clinical trials to slow cognitive decline in patients with mild cognitive impairment or early Alzheimer’s disease. The approval offers patients renewed hope after repeated failures to find effective treatments. The announcement came following a highly […]
Blood Tests and a New Promising Drug for Alzheimer’s Are Here. Here’s What You Need to Know.
Q. I know Alzheimer’s research, diagnostic tools, and treatments have come a long way in the past few years, with several new options having been introduced. But, I’m curious — do any of these options really work or even show real promise? A. Alzheimer’s disease research is at an important moment, with the emergence of […]